| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |